Julphar (Gulf Pharmaceutical Industries) is a leading biopharmaceutical company dedicated to advancing healthcare through science, innovation, and world-class manufacturing. Founded in 1980 and headquartered in Ras Al Khaimah, United Arab Emirates, Julphar has built a strong legacy of developing and delivering trusted medicines that improve lives across global markets.

Today, Julphar develops, manufactures, and commercializes a diversified portfolio of pharmaceutical and biopharmaceutical products. Building on decades of expertise in insulin and biologics manufacturing, the company combines advanced manufacturing capabilities with partnerships across leading global technology, research, and biopharmaceutical organizations to deliver innovative medicines and address evolving patient needs.

With approximately 3,000 employees, 10 internationally accredited manufacturing facilities, and a commercial presence spanning more than 40 countries across five continents, Julphar delivers innovative and accessible medicines that improve the lives of millions of patients worldwide.